Vident Advisory’s Mesa Laboratories MLAB Stock Holding History

Vident Advisory’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$757K	Hold	7,608	–	–	0.01%	1133
2026 Q1	$673K	Buy	+7,608	New	+$656K	0.01%	1080

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vident Advisory's MLAB Position: Q2 2026 in Review

Vident Advisory held its Mesa Laboratories (MLAB) position steady in Q2 2026 at 7,608 shares worth $757K. The position accounts for 0.01% of the portfolio, ranked #1133.

Vident Advisory first reported a position in MLAB in Q1 2026 and has held it in 2 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Vident Advisory held 7,608 shares of Mesa Laboratories worth $757K as of Q2 2026.
Vident Advisory left its Mesa Laboratories share count unchanged in Q2 2026.
Mesa Laboratories made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1133 holding.
Vident Advisory first reported a position in Mesa Laboratories in Q1 2026 and has held it in 2 quarters since.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.